EDGAR Filing Documents for 0001047469-15-001859

Form S-3 - Registration statement under Securities Act of 1933:

SEC Accession No. 0001047469-15-001859

Filing Date

2015-03-09

Accepted

2015-03-09 17:28:10

Documents

Document Format Files

Seq	Description	Document	Type	Size
1	S-3	a2223434zs-3.htm	S-3	351435
2	EX-1.2	a2223434zex-1_2.htm	EX-1.2	319237
3	EX-4.1	a2223434zex-4_1.htm	EX-4.1	326251
4	EX-4.2	a2223434zex-4_2.htm	EX-4.2	329669
5	EX-5.1	a2223434zex-5_1.htm	EX-5.1	38429
6	EX-23.2	a2223434zex-23_2.htm	EX-23.2	3520
7	G941268.JPG	g941268.jpg	GRAPHIC	23815
8	G341694.JPG	g341694.jpg	GRAPHIC	17172
9	G652303.JPG	g652303.jpg	GRAPHIC	17436
	Complete submission text file	0001047469-15-001859.txt		1450446

Mailing Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837

Business Address 399 THORNALL STREET FIRST FLOOR EDISON NJ 08837 732-902-4000

ContraVir Pharmaceuticals, Inc. (Filer) CIK: 0001583771 (see all company filings)